0001562180-22-005610.txt : 20220706 0001562180-22-005610.hdr.sgml : 20220706 20220706201106 ACCESSION NUMBER: 0001562180-22-005610 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220701 FILED AS OF DATE: 20220706 DATE AS OF CHANGE: 20220706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reilly Thomas Charles CENTRAL INDEX KEY: 0001827590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 221070404 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-07-01 false 0000897448 AMARIN CORP PLC\UK AMRN 0001827590 Reilly Thomas Charles C/O AMARIN PHARMA, INC. 440 US HIGHWAY 22 BRIDGEWATER NJ 08807 false true false false SVP and CFO Stock Option (Right to Buy) 1.44 2022-07-01 4 A false 100000.00 0.00 A 2032-07-01 Ordinary Shares 100000.00 100000.00 D Restricted Stock Units 0.00 2022-07-01 4 A false 100000.00 0.00 A Ordinary Shares 100000.00 100000.00 D On July 1, 2022, the Reporting Person was granted an option to purchase 100,000 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on June 20, 2023 and the balance to vest ratably over the subsequent 12 calendar quarters on the twentieth (20th) day of each September, December, March and June. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. On July 1, 2022, the Reporting Person was granted 100,000 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of June 20, 2023, June 20, 2024 and June 20, 2025. Not applicable. In the case of a Change of Control (as defined in the Issuer's stock incentive plan), the grants described in this Form 4 vest in full. As of the date of this Form 4, the Reporting Person holds the right to acquire an aggregate of 300,000 Ordinary Shares of the Issuer in the form of stock options and RSUs outstanding under the Issuer's stock incentive plan, including certain performance-based RSUs that are earned (and reportable on a Form 4) only if certain pre-defined operational milestones are achieved and then vest only if the recipient remains with the company for an extended period of time. /s/ Thomas Charles Reilly 2022-07-06